Healthcare & Medical Devices Global On demand · 24-48h

Global Sterile Urine Cups Market Strategic Research Report

Global Sterile Urine Cups Market Strategic Research Report
$3,500 USD
Market Research Reports
Strategic Research Report
Global Sterile Urine Cups Market
$94.42025
5.3%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: 30 ml, 60 ml, 120 ml, Others

By Application: Hospitals, Clinics, Laboratories, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Norgen Biotek, Labcon, AdvaCare Pharma, Savyon Diagnostics, Biosigma, FL Medical, Miniplast, MK Plast, Greiner Bio-One, Hunan Pingan Medical, MOSLAB, Jiangsu Kangjian, Iron Will Biomedical, MEDICO TECHNOLOGY, CITOTEST LABWARE, Jiangsu Kangjie Medical, Jiangsu Changfeng Medical, Haimencity Kahotest, Jiangsu Suyi Medical

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 136 pages
Market size 2025
$94.4
Million USD
Forecast CAGR
5.3%
2025-2032
Forecast 2032
$135.5
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

نظرة عامة

Scope of the Report

The global Sterile Urine Cups market size is predicted to grow from US$ 94.40 million in 2025 to US$ 135 million in 2032; it is expected to grow at a CAGR of 5.3% from 2026 to 2032.

In 2025, global sales of Sterile Urine Cups reached approximately 152 million units, with an average market price of about USD 0.6 per unit, an annual production capacity of roughly 200 million units, and an industry-average gross margin of approximately 31%.

A Sterile Urine Cup is a disposable medical container used for the collection, storage, and transportation of human urine samples. Its main functions include convenient sampling, contamination prevention, leak-proof sealing, and meeting laboratory or point-of-care analysis requirements in terms of capacity and material. Typically made from food-grade or medical-grade plastic, urine cups often feature screw-on or snap-on lids, with some models including graduated markings, spill-proof, antimicrobial coatings, or temperature-resistant designs. Key considerations are hygiene, non-toxicity, chemical resistance, and compliance with medical device standards.

Upstream of urine cups includes plastic raw materials (PP, PS), lid and seal suppliers, and printing or marking vendors. Manufacturing typically involves injection molding and automated assembly, classified as a light industrial consumable. Downstream users are hospitals, clinical labs, physical examination centers, drug-testing institutions, and research facilities. As a disposable consumable, usage scales directly with sample volume; high-throughput labs may consume hundreds of thousands to millions of cups annually, while routine health centers maintain significant inventory for continuous supply. The supply chain cost structure is dominated by raw materials, followed by mold depreciation, labor, and packaging/transport, while downstream consumption remains stable and inelastic, ensuring continuous market demand.

Global key Sterile Urine Cups players cover Norgen Biotek, Labcon, AdvaCare Pharma, Savyon Diagnostics, Biosigma, etc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Sterile Urine Cups market?

What factors are driving Sterile Urine Cups market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Sterile Urine Cups market opportunities vary by end market size?

How does Sterile Urine Cups break out by Type, by Application?

This report presents a comprehensive overview of the global Sterile Urine Cups market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • 30 ml
  • 60 ml
  • 120 ml
  • Others

Segment by Material

  • PP
  • PVC
  • PS

Segment by Application

  • Hospitals
  • Clinics
  • Laboratories
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Sterile Urine Cups market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hospitals, Clinics, Laboratories evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Sterile Urine Cups Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 5.3%
Regional growth momentum
Market share by segment
Key metrics
Base value
$94.4
2025
Forecast
$135.5
2032
CAGR
5.3%
2025–2032
Regions
5
global
Key companies
Norgen BiotekLabconAdvaCare PharmaSavyon DiagnosticsBiosigmaFL MedicalMiniplastMK Plast
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
30 ml60 ml120 mlOthers
By Application
HospitalsClinicsLaboratoriesOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 30 ml
  • 3.1.3 60 ml
  • 3.1.4 120 ml
  • 3.1.5 Others
  • 3.1.6 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospitals
  • 4.1.3 Clinics
  • 4.1.4 Laboratories
  • 4.1.5 Others
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Norgen Biotek
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Labcon
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 AdvaCare Pharma
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Savyon Diagnostics
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Biosigma
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 FL Medical
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Miniplast
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 MK Plast
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Greiner Bio-One
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Hunan Pingan Medical
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 MOSLAB
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Jiangsu Kangjian
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Iron Will Biomedical
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 MEDICO TECHNOLOGY
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 CITOTEST LABWARE
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Jiangsu Kangjie Medical
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Jiangsu Changfeng Medical
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Haimencity Kahotest
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Jiangsu Suyi Medical
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Sterile Urine Cups market?
The global Sterile Urine Cups market is estimated at US$ 94.4 million in 2025 (base year) and is projected to reach US$ 135 million by 2032.
What is the forecast CAGR for the Sterile Urine Cups market?
The market is expected to grow at a CAGR of 5.3% from 2026 to 2032, expanding from US$ 94.4 million in 2025 to US$ 135 million in 2032, roughly 1.4 times its base-year value.
What is Sterile Urine Cups?
In 2025, global sales of Sterile Urine Cups reached approximately 152 million units, with an average market price of about USD 0.6 per unit, an annual production capacity of roughly 200 million units, and an industry-average gross margin of approximately 31%.
How is the Sterile Urine Cups market segmented by type?
By type, the market is segmented into 30 ml, 60 ml, 120 ml and Others.
What are the key applications of Sterile Urine Cups?
Key applications covered include Hospitals, Clinics, Laboratories and Others.
Which companies are profiled in the Sterile Urine Cups market report?
Key players profiled include Norgen Biotek, Labcon, AdvaCare Pharma, Savyon Diagnostics, Biosigma, FL Medical, Miniplast and MK Plast, among 19 companies covered in total.
What geographies does the Sterile Urine Cups market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Sterile Urine Cups?
What factors are driving Sterile Urine Cups market growth, globally and by region?
Who should buy the Sterile Urine Cups market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hospitals, Clinics and Laboratories, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Sterile Urine Cups market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from ‏3,500.00 US$
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.